What is the pediatric dosage for polyethylene glycol (PEG) for constipation relief?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosage for Polyethylene Glycol (PEG)

For functional constipation in children, start PEG 3350 at 0.8 g/kg/day (or approximately 1 g/kg/day initially) and titrate to achieve 1-2 soft, painless stools daily. 1, 2, 3

Age-Specific Dosing

Infants and Toddlers (<18 months)

  • Initial dose: 0.88 g/kg/day 1
  • Effective maintenance dose: 0.78 g/kg/day (range 0.26-1.26 g/kg/day) 1
  • Efficacy: 97.6% response rate in this age group 1
  • Safety profile: Similar to older children, with only transient diarrhea requiring dose adjustment 1

Children 18 months to 2 years

  • Initial dose: 1 g/kg/day 2
  • Short-term effective dose: 1.1 g/kg/day (mean at 2 months) 2
  • Long-term effective dose: 0.8 g/kg/day (mean at 11 months) 2
  • Efficacy: 85% relief at short-term follow-up, 91% at long-term follow-up 2

Children >2 years

  • Initial dose: 1 g/kg/day 3
  • Mean effective dose: 0.84 g/kg/day (range 0.27-1.42 g/kg/day) 3
  • Alternative dosing: 1.0-1.5 g/kg/day has been studied with 95.3% success rate 4

Titration Strategy

Adjust the dose every 3 days based on stool frequency and consistency to achieve the target of 1-2 soft stools per day. 2, 3

  • If diarrhea occurs, reduce the dose immediately—this is the most common side effect and resolves with dose adjustment 1, 2
  • No maximum dose is clearly defined, but titrate based on symptom response and tolerability 5
  • PEG maintains efficacy over 6 months without loss of effect 5

Special Considerations for Colonoscopy Preparation

For colonoscopy preparation specifically, use 1.5 g/kg/day for 4 days prior to the procedure, with a clear liquid diet on day 4. 6

  • This higher dose is appropriate for bowel cleansing rather than chronic constipation management 6
  • Maintain adequate hydration, especially in young children 6
  • PEG causes significantly fewer mucosal lesions (2.3%) compared to sodium phosphate (24.5%) 6

Safety Profile

PEG 3350 is well-tolerated across all pediatric age groups with minimal adverse effects. 1, 2, 3

  • Common side effects: bloating, abdominal discomfort, flatulence, and transient diarrhea that resolves with dose adjustment 5, 1
  • No children discontinued therapy due to adverse effects in major studies 2
  • PEG is tasteless and has superior palatability compared to alternatives like milk of magnesia 7, 3
  • Ensure adequate hydration as this is an osmotic laxative 5

Clinical Outcomes

PEG significantly increases stool frequency from baseline 2.3 stools/week to 16.9 stools/week and improves stool consistency. 3

  • In children with encopresis, soiling events decrease from 10 episodes/week to 1.3 episodes/week 3
  • Response is durable over long-term treatment (mean 11 months) 2
  • PEG has at least equivalent efficacy to liquid paraffin but with fewer adverse events 4

References

Research

Polyethylene glycol for constipation in children younger than eighteen months old.

Journal of pediatric gastroenterology and nutrition, 2004

Research

Clinical efficacy and safety of polyethylene glycol 3350 versus liquid paraffin in the treatment of pediatric functional constipation.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Preparation for Colonoscopy in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Polyethylene glycol without electrolytes for children with constipation and encopresis.

Journal of pediatric gastroenterology and nutrition, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.